Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Rheumatology

• Publication date

  2012-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/rheumatology/kes225PMID 22923750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss.

  2012cited by this paper
• Fetal outcome in autoimmune diseases.

  2012cited by this paper
• Pathogenesis of antiphospholipid syndrome: understanding the antibodies

  2011cited by this paper
• Classical complement activation as a footprint for murine and human antiphospholipid antibody‐induced fetal loss

  2011cited by this paper
• Early Elevations of the Complement Activation Fragment C3a and Adverse Pregnancy Outcomes

  2011cited by this paper
• Complement activation in animal and human pregnancies as a model for immunological recognition.

  2011cited by this paper
• Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE Cohort

  2011cited by this paper
• Adjusted prophylactic doses of nadroparin plus low dose aspirin therapy in obstetric antiphospholipid syndrome. A prospective cohort management study.

  2011cited by this paper
• The geoepidemiology of the antiphospholipid antibody syndrome.

  2010cited by this paper
• Predictors of Pregnancy Outcome in Antiphospholipid Syndrome: A Review

  2010cited by this paper
• Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.

  2008cited by this paper
• Discussion: 'racial disparity in preterm birth' by Kistka et Al.

  2007cited by this paper
• Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process?

  2007cited by this paper
• Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies.

  2007cited by this paper
• International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

  2006cited by this paper
• A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.

  2005cited by this paper
• Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation

  2004cited by this paper
• Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss

  2002cited by this paper

• Development and validation of a support vector machine-based nomogram for diagnosis of obstetric antiphospholipid syndrome.

  2025cites this paper
• Immune-mediated mechanisms and maternal-fetal interface dysfunction in obstetric antiphospholipid syndrome

  2025cites this paper
• Predicting risk of the subsequent early pregnancy loss in women with recurrent pregnancy loss based on preconception data

  2024cites this paper
• Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group.

  2023cites this paper
• Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes

  2023cites this paper
• Fat-soluble vitamins

  2022cites this paper
• Alternative pathway activation in pregnancy, a measured amount “complements” a successful pregnancy, too much results in adverse events

  2022cites this paper
• Complement regulation in ovine lymph nodes during early pregnancy

  2021cites this paper
• Risk factors for pregnancy morbidity in women with antiphospholipid syndrome.

  2021cites this paper
• A novel update on vitamin D in recurrent pregnancy loss

  2021cites this paper
• Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies

  2021cites this paper
• Anti‐phospholipid antibodies and reproductive failures

  2020cites this paper
• P74 Complement variations in systemic lupus erythematosus pregnancies

  2020cites this paper
• Antiphospholipid Syndrome.

  2020cites this paper
• Adverse Pregnancy Outcomes after Multi-Professional Follow-Up of Women with Systemic Lupus Erythematosus: An Observational Study from a Single Centre in Sweden

  2020cites this paper
• The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy

  2020cites this paper
• Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond

  2020cites this paper
• Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome

  2019cites this paper
• Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies

  2019cites this paper
• Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond

  2019cites this paper
• Management of pregnant women with antiphospholipid antibodies

  2019cites this paper
• Complement in the Pathophysiology of the Antiphospholipid Syndrome

  2019cites this paper
• Complementemia in pregnancies with antiphospholipid syndrome

  2019cites this paper
• Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications

  2018cites this paper
• Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies

  2018cites this paper
• Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies

  2018influential citation
• The treatment of anti-phospholipid syndrome: A comprehensive clinical approach.

  2018cites this paper
• Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.

  2018cites this paper
• Antiphospholipid syndrome: An update on risk factors for pregnancy outcome.

  2018cites this paper
• Obstetric Manifestations of the Antiphospholipid Syndrome

  2017cites this paper
• Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review

  2017cites this paper
• Delineating the deranged immune system in the antiphospholipid syndrome.

  2016cites this paper
• Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies

  2016cites this paper
• Phospholipid-independent Binding of j 52 glycoprotein I by IgA from Patients with Antipnospholipia Syndrome

  2015cites this paper
• Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.

  2014cites this paper
• The Important Roles of C4d in Systemic Lupus Erythematosus

  2014cites this paper
• Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome

  2014cites this paper
• Summary of the 9th meeting of the European Forum on Antiphospholipid Antibodies

  2014cites this paper
• CD8+DR+ T-Cells and C3 Complement Serum Concentration as Potential Biomarkers in Thrombotic Antiphospholipid Syndrome

  2014cites this paper
• Chapter 34 – Antiphospholipid Syndrome

  2014cites this paper
• Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases.

  2013cites this paper
• Role of the complement in pregnancy with antiphospholipid syndrome: mechanisms of pathogenesis and clinical aspects

  2013cites this paper
• Obstetric and vascular APS: Same autoantibodies but different diseases?

  2012cites this paper
• Predictors of Pregnancy Outcome in Antiphospholipid Syndrome: A Review

  2010cites this paper